as on December 20, 2025 at 2:29 am IST
Day's Low
Day's High
1.90%
Downside
5.71%
Upside
52 Week's Low
52 Week's High
37.04%
Downside
89.52%
Upside
Check Fate Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$121.1M
EPS (TTM)
-1.1489
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-2.29
Industry PE ratio
-3.2295762711864406
PEG Ratio
0EBITDA
-145.3M
Revenue (TTM)
7.1M
Profit Margin
0.00%
Return On Equity TTM
-52.35%
Track how Fate Therapeutics Inc P/E has moved over time to understand its valuation trends.
Fate Therapeutics Inc in the last 5 years
Lowest (-45.20x)
March 31, 2021
Industry (-3.23x)
December 20, 2025
Today (-2.29x)
December 20, 2025
Highest (-0.80x)
June 30, 2025
Today’s Price to Earnings Ratio: -2.29x
Compare market cap, revenue, PE, and other key metrics of Fate Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| HOLD | $121.1M | -98.87% | -2.29 | 0.00% | |
| BUY | $37.3B | 371.01% | -16.34 | -264.83% | |
| BUY | $52.3B | 181.08% | 1237.62 | 1.36% | |
| BUY | $114.7B | 92.72% | 31.44 | 31.35% | |
| BUY | $79.4B | 53.93% | 17.95 | 32.13% |
The Fate Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Fate Therapeutics Inc investment value today
Current value as on today
₹67,731
Returns
Returns from Fate Therapeutics Inc Stock
Dollar Returns*
₹5,231 (+5.23%)
Based on 26 analysts
42.31%
Buy
53.85%
Hold
3.85%
Sell
Based on 26 analysts, 53.85% of analysts recommend a 'HOLD' rating for Fate Therapeutics Inc. Average target price of $4.94
Get share price movements and forecasts by analysts on Fate Therapeutics Inc.
What analysts predicted
78.74%UPSIDE
Target Price
$4.94
Current Price
$1.05
Analyzed by
26 Analysts
Target
$4.94
Fate Therapeutics Inc target price $4.94, a slight upside of 78.74% compared to current price of $1.05. According to 26 analysts rating.
Search interest for Fate Therapeutics Inc Stock has decreased by -33% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 4 quarters, -52.15M → -32.25M (in $), with an average increase of 18.2% per quarter
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 148.2% return, outperforming this stock by 185.7%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 779.0% return, outperforming this stock by 870.4%
Price Dip
![]()
In the last 3 years, FATE stock has moved down by -91.4%
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 1.90M → 1.74M (in $), with an average decrease of 8.7% per quarter
| Organisation | Fate Therapeutics Inc |
| Headquarters | 12278 Scripps Summit Drive, San Diego, CA, United States, 92131 |
| Industry | Health Technology |
| CEO | Dr. Bahram Valamehr M.B.A., Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Kamal Adawi M.S., MBA | Chief Financial Officer |
Ms. Jessica Francis | Vice President Of Human Resources & Operations |
Mr. Victor Hong | Vice President of Corporate Development & Finance |
Mr. Andrew Henry | Senior Vice President of Clinical Operations |
Dr. Tunde Babalola Ph.D. | Senior Vice President of Technical Operations |
Dr. Bahram Valamehr M.B.A., Ph.D. | President, CEO & Director |
Ms. Cindy R. Tahl J.D. | Chief Legal & Compliance Officer and Corporate Secretary |
Dr. Yu Cai J.D., Ph.D. | Head of Intellectual Property & Assistant General Counsel |
Ms. Kate Duvall | Corporate Controller |
Fate Therapeutics Inc share price today is $1.05 as on at the close of the market. Fate Therapeutics Inc share today touched a day high of $1.11 and a low of $1.03.
Fate Therapeutics Inc share touched a 52 week high of $1.99 on and a 52 week low of $0.66 on . Fate Therapeutics Inc stock price today i.e. is closed at $1.05,which is 47.24% down from its 52 week high and 58.84% up from its 52 week low.
Fate Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Fate Therapeutics Inc (FATE) shares with as little as ₹89.552 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹895.52 in Fate Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Fate Therapeutics Inc share’s latest price of $1.05 as on December 20, 2025 at 2:29 am IST, you will get 9.5238 shares of Fate Therapeutics Inc. Learn more about
fractional shares .
Fate Therapeutics Inc stock has given -98.87% share price returns and 21.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?